4.92
price down icon5.93%   -0.31
after-market Dopo l'orario di chiusura: 4.92
loading

Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie

pulisher
12:46 PM

Can a trend reversal in Aldeyra Therapeutics Inc. lead to recoveryWall Street Watch & Verified Trade Idea Suggestions - newser.com

12:46 PM
pulisher
07:01 AM

Sentiment analysis tools applied to Aldeyra Therapeutics Inc.Weekly Market Summary & Real-Time Price Movement Reports - newser.com

07:01 AM
pulisher
05:26 AM

Live market analysis of Aldeyra Therapeutics Inc.July 2025 Decliners & Accurate Technical Buy Alerts - newser.com

05:26 AM
pulisher
05:01 AM

Aldeyra Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com

05:01 AM
pulisher
03:51 AM

Smart tools for monitoring Aldeyra Therapeutics Inc.’s price action - newser.com

03:51 AM
pulisher
02:14 AM

How to interpret RSI for Aldeyra Therapeutics Inc. stockJuly 2025 Action & Daily Growth Stock Investment Tips - newser.com

02:14 AM
pulisher
02:14 AM

Analyzing net buyer seller activity in Aldeyra Therapeutics Inc.Portfolio Gains Summary & Safe Entry Zone Identification - newser.com

02:14 AM
pulisher
Nov 03, 2025

Published on: 2025-11-03 21:46:12 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Evaluating Aldeyra Therapeutics Inc. with trendline analysis2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Aldeyra’s Experimental Drug Shows Promising Results In Mid-Stage Alcohol Hepatitis Trial - MSN

Nov 03, 2025
pulisher
Nov 03, 2025

Applying Wyckoff theory to Aldeyra Therapeutics Inc. stockWeekly Loss Report & Weekly High Return Stock Forecasts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Aldeyra Therapeutics Inc. stock resilient to inflationWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Aldeyra Therapeutics Inc. stock performs in weak economyJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Intraday pattern recognizer results for Aldeyra Therapeutics Inc.2025 Top Decliners & Growth Focused Stock Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Aldeyra Therapeutics Inc. stock split again soonShort Setup & Smart Money Movement Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Aldeyra Therapeutics Inc. stock could see breakout soonJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why analysts upgrade Aldeyra Therapeutics Inc. stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Automated trading signals detected on Aldeyra Therapeutics Inc.Market Trend Review & Free Reliable Trade Execution Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Combining price and volume data for Aldeyra Therapeutics Inc.Stock Surge & Safe Capital Allocation Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Aldeyra Therapeutics Inc. stock attractive for ETFsIndex Update & Weekly High Momentum Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Understanding Aldeyra Therapeutics Inc.’s price movementTrade Entry Report & Reliable Price Action Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Aldeyra Therapeutics Inc. stock affected by interest rate hikes2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

What insider trading reveals about Aldeyra Therapeutics Inc. stock2025 Momentum Check & High Win Rate Trade Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Aldeyra refocuses pipeline on next-gen RASP modulators despite positive phase II success - Indian Pharma Post

Oct 31, 2025
pulisher
Oct 31, 2025

Is Aldeyra Therapeutics Inc. stock dividend yield sustainableJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Catalyst Monitor Outlook, Q4 2025 Report: Pipeline Advances with Key Approvals and Trials: Featuring Cytokinetics's Aficamten, Aldeyra's Reproxalap, GSK's Depemokimab - Yahoo Finance

Oct 31, 2025
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
Capitalizzazione:     |  Volume (24 ore):